- Home
- GLDG vs CERS Comparison
GLDG vs CERS Comparison
Compare GLDG & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDG
- CERS
- Stock Information
- Founded
- GLDG 2009
- CERS 1991
- Country
- GLDG Canada
- CERS United States
- Employees
- GLDG N/A
- CERS N/A
- Industry
- GLDG Precious Metals
- CERS EDP Services
- Sector
- GLDG Basic Materials
- CERS Technology
- Exchange
- GLDG Nasdaq
- CERS Nasdaq
- Market Cap
- GLDG 317.0M
- CERS 276.0M
- IPO Year
- GLDG N/A
- CERS 1997
- Fundamental
- Price
- GLDG $1.41
- CERS $1.51
- Analyst Decision
- GLDG Strong Buy
- CERS Strong Buy
- Analyst Count
- GLDG 2
- CERS 2
- Target Price
- GLDG $3.50
- CERS $3.50
- AVG Volume (30 Days)
- GLDG 4.4M
- CERS 1.3M
- Earning Date
- GLDG 10-10-2025
- CERS 11-06-2025
- Dividend Yield
- GLDG N/A
- CERS N/A
- EPS Growth
- GLDG N/A
- CERS N/A
- EPS
- GLDG N/A
- CERS N/A
- Revenue
- GLDG N/A
- CERS $192,510,000.00
- Revenue This Year
- GLDG N/A
- CERS $19.07
- Revenue Next Year
- GLDG N/A
- CERS $12.03
- P/E Ratio
- GLDG N/A
- CERS N/A
- Revenue Growth
- GLDG N/A
- CERS 13.25
- 52 Week Low
- GLDG $0.71
- CERS $1.12
- 52 Week High
- GLDG $1.80
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- GLDG 49.85
- CERS 48.89
- Support Level
- GLDG $1.38
- CERS $1.48
- Resistance Level
- GLDG $1.71
- CERS $1.66
- Average True Range (ATR)
- GLDG 0.13
- CERS 0.09
- MACD
- GLDG -0.03
- CERS -0.02
- Stochastic Oscillator
- GLDG 27.10
- CERS 11.36
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.